Di Cui

Epigenetic Co-Deregulation of EZH2/TET1 is a Senescence-Countering, Actionable Vulnerability in Triple-Negative Breast Cancer

Yong Yu, Jingjing Qi, Jieyi Xiong et al. · Theranostics · 2019 · 71 citations · Full text

Medicine, Cancer Biology, Oncology +17

High-Yield Human Induced Pluripotent Stem Cell-Derived Monocytes and Macrophages Are Functionally Comparable With Primary Cells

Di Cui, Alexandra Franz, Sophie Fillon et al. · Frontiers in Cell and Developmental Biology · 2021 · 34 citations · Full text

Life Sciences, Cell Biology, Immunology +13

Targeting Wnt/β-Catenin Signaling by TET1/FOXO4 Inhibits Metastatic Spreading and Self-Renewal of Cancer Stem Cells in Gastric Cancer

Jingjing Qi, Di Cui, Qi‐Nian Wu et al. · Cancers · 2022 · 25 citations · Full text

Medicine, Cancer Biology, Oncology +17

Ag_{2–3<i>x</i>}Bi<i>_x</i>S Quantum Dots as Single-Component Theranostic Agents for Second Near-Infrared Fluorescence Imaging-Guided Photothermal Therapy

Di Cui, Lixia Han, Wei Jiang et al. · ACS Applied Nano Materials · 2023 · 14 citations

Natural Sciences, Biomedical Engineering, Materials Science +17

Transcriptome profiling of tolerogenic dendritic cells conditioned with dual mTOR kinase inhibitor, AZD8055

Shao Su, Di Cui, Chenyang Ma et al. · International Immunopharmacology · 2020 · 10 citations

Life Sciences, Immunology, Molecular Biology +16